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Abstract 
Background: The C-allele of the aquaporin (AQP5) -1364A/C polymorphism is associated with decreased AQP5 
expression but increased 30-day survival in patients with severe sepsis. AQP5 expression might affect survival via an 
impact on cell migration. Consequently, we tested the hypothesis that (1) Aqp5 knockout (KO) compared to wild type 
(WT) mice show an increased survival following lipopolysaccharide (LPS) administration, and that (2) AQP5 expression 
and the AQP5 -1364A/C polymorphism alters immune cell migration.
Methods: We investigated Aqp5-KO and wild type mice after intraperitoneal injection of either E.coli lipopolysac-
charide (LPS, serotype O127:B8, 20 mg/kg) or saline. Furthermore, neutrophils of volunteers with the AA-AQP5 or AC/
CC-AQP5- genotype were incubated with 10−8 M Chemotactic peptide (fMLP) and their migration was assessed by a 
filter migration assay. Additionally, AQP5 expression after fMLP incubation was analyzed by RT-PCR and Western blot. 
Moreover, migration of AQP5 overexpressing Jurkat cells was studied after SDF-1α-stimulation. We used exact Wil-
coxon–Mann–Whitney tests; exact Wilcoxon signed-rank tests and the Kaplan–Meier estimator for statistical analysis.
Results: Fifty-six percent of Aqp5-KO but only 22% of WT mice survived following LPS-injection. WT mice showed 
increased neutrophil migration into peritoneum and lung compared to Aqp5-KO mice. Target-oriented migration of 
neutrophils was seen after 0.5 h in AA-genotype cells but only after 1.5 h in AC/CC-genotype cells, with a threefold 
lower migrating cell count. AQP5 overexpressing Jurkat cells showed a 2.4 times stronger migration compared to 
native Jurkat cells.
Conclusion: The AQP5 genotype may influence survival following LPS by altering neutrophil cell migration.
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Background
Although wide variability exists regarding the out-
come from severe sepsis, some of this variability may 
be caused by genetic variability, as shown in twin and 
adoption studies [1–4]. A potential candidate gene for 
investigation is the gene encoding aquaporin (AQP) 
5 [5], which mediates key mechanisms of inflamma-
tion that prevail in sepsis, including cell migration 
and proliferation [6], activity of the renin–angioten-
sin–aldosterone system (RAAS) [7], and the transport 
of water across biological membranes [8]. Previously, 
we described a functional, and common (70% AA, 23% 
AC, 7% CC) single nucleotide (−1364A/C, rs3759129) 
polymorphism in the AQP5 gene promoter [7]. Substi-
tution of C for A at position—1364 was associated with 
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expression. It was also a strong, independent prognos-
tic factor for decreased 30-day mortality in patients 
with severe sepsis [9]. The estimated hazard ratio of 
nearly 4 for the AC/CC-genotypes compared with the 
homozygous AA genotype not only suggests that the 
C-allele of the AQP5-1364A/C polymorphism may have 
important effects on the AQP5 expression in severe 
sepsis, but also that there is a potential relevance of the 
AQP5 expression in severe sepsis. However, the under-
lying molecular and pathophysiological alterations 
linking a decreased AQP5 expression in C allele carri-
ers to 30-day mortality is unknown.
In the search for these mechanisms, our previous 
research [7] suggested an impact of a decreased AQP5 
expression in C-allele carriers on sepsis survival via its 
influence on the renin–angiotensin–aldosterone system, 
which however could not be confirmed [9]. Therefore, 
our research focused on further possible mechanisms. 
Since AQP5 expression also mediates cell migration, 
which is yet another inflammatory key mechanism and 
involves transient formation of membrane protrusions 
(lamellipodia and membrane ruffles) at the migrating 
cell’s leading edge [6], we speculated that the AQP5 
expression might influence sepsis survival due to its 
influence on immune cell migration. During cell migra-
tion aquaporins facilitate water influx through the cell 
membrane and cause a local hydrostatic pressure caus-
ing cell membrane expansion [6]. This expansion is 
stabilized by actin polymerization and mediates migra-
tion [6]. In addition it was previously demonstrated 
that Aqp5-KO mice show increased bacterial load after 
infection but decreased NFκB expression and mucus 
secretion compared to WT mice [10]. To this end, a 
decreased AQP5 expression may decrease immune cell 
migration and may subsequently alter the inflamma-
tory chain during sepsis. The migration of neutrophils 
is essential in immune response during sepsis [11] and 
its regulation is critical for sepsis outcome as sufficient 
neutrophil migration is critical for pathogen clearance 
but excessive neutrophil migration is associated tis-
sue damage and subsequent organ dysfunction [12]. In 
addition regulation of AQP5 expression in neutrophils 
has not been studied yet and was therefore addressed 
with this study.
Accordingly, we prospectively tested the following 
hypotheses:
1. The survival rate in Aqp5-KO mice is different than 
in wild type mice after lipopolysaccharide induced 
inflammation.
2. The AQP5 expression and the AQP5-1364A/C geno-
type is associated with impaired cell migration.
Methods
Mice
Experiments were conducted in accordance with German 
and local governmental regulations, complying with both 
the European Community and the American Physiologi-
cal Society and the Guide for the Care and Use of Labo-
ratory Animals (National Institute of Health publication 
85-23, revised 1996) guidelines. Aqp5 (−/−) [knockout 
(KO)] and wild type recombinant inbred from 129SvJ/
Black Swiss mice were provided by Prof. Anil Menon, 
Cincinnati, and generated as previously described [13].
Genotyping of mice
Mice were genotyped with mouse DNA extracted from 
an ear biopsy as described previously [14].
Animal preparation
We investigated Aqp5-KO (−/−) and wild type (+/+) 
mice after an intraperitoneal (i.p.) injection of either 
Escherichia coli lipopolysaccharide (LPS, 20  mg/
kg in saline [15], serotype O127:B8, Sigma-Aldrich, 
Taufkirchen, Germany) or an equivalent amount of 
pyrogen-free saline. After 4.5 h and 24 h post LPS/saline 
injection 100  µl retro orbital blood was collected. The 
serum layer was removed after clotting and centrifuga-
tion and stored at −80 °C. IL-10 and TNF-α concentra-
tions were determined using Legend Max Elisa Plates 
(BioLegend, San Diego, CA, USA). The survival and the 
state of health (score sheet) of the mice were observed 
every 6  h. In the score sheet points (zero for no abnor-
mality and 20 for worst case) were given for body weight, 
general condition, behavior, clinical findings and secre-
tions. Due to these points the disease score was calcu-
lated (Additional file 1).
Eight Aqp5-KO (−/−) and eight wild type (+/+) mice 
were killed 3  h after LPS or saline injection by cervical 
dislocation to study neutrophil migration. Peritoneal lav-
age and lungs were harvested and right lungs were snap 
frozen whereas left lungs were stored in formalin and 
paraffin-embedded (Paraplast Xtra-plus, Sigma-Aldrich, 
Munich, Germany).
MPO activity assay
Myeloperoxidase (MPO) activity was measured as a 
marker for neutrophil infiltration. The right lungs were 
homogenized in buffer containing 10 mM NEM (Sigma-
Aldrich, Taufkirchen, Germany) and then solubilized in 
buffer containing 0,5% HTA-Br. MPO activity was deter-
mined by the use of Myeloperoxidase activity assay kit 
(abcam, Cambridge, UK). In addition protein amount 
was determinated using RotiQuant universal (Roth, 
Karlsruhe, Germany).
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Flow cytometric analysis of peritoneal lavage
For flow cytometry (FACS) cell suspensions were col-
lected by a lavage of the peritoneum with 5  ml PBS 
containing 5  mM EDTA. For FACS analysis, cells were 
stained with the appropriate antibodies (APC antimouse 
Ly6g/Ly6C (Gr-1) clone RB6-8C5, BioLegend, San Diego, 
CA, USA; Antimouse CD11c FITC, clone N418, eBio-
science, Frankfurt, Germany), after blocking FcRs with 
anti-CD16/32. Cells were analyzed on a BD FACSCanto 
II (Heidelberg, Germany). Data were analyzed with Flow-
ing Software 2.
Neutrophils staining in lung tissue with naphthol AS‑d 
chloroacetate (NASDCL)‑esterase
Naphthol AS-d chloroacetate (NASDCL)-esterase was 
used to detect neutrophils on tissue sections. Paraffin left 
lung sections (1–2 μm thick) were mounted on slides and 
de-paraffinized. Staining with naphtol AS-d chloroacetate 
staining solution (containing naphtol-AS-d-chloracetat in 
dimethyl sulfoxide dimethyl, pararosaniline and sodium 
nitrite) was performed for 30  min. Finally, the sections 
were counterstained with Mayer’s hematoxylin.
Patients
The study was reviewed and approved by the Medical 
Faculty’s Ethics Committee of the Duisburg-Essen Uni-
versity. The samples used in this study have been used 
for several other studies before [3, 4, 9] thus no addi-
tional material had to be collected. Patients with sepsis 
were considered eligible when they fulfilled the 2001 
American College of Chest Physicians/Society of Criti-
cal Care Medicine Consensus conference guidelines 
[16]. Patients with sepsis were enrolled on the day when 
the sepsis was first diagnosed and arterial and venous 
blood was sampled. Afterwards, blood tests, genotyping, 
cytokine determination, microbiology cultures, and RNA 
extraction were performed. Informed consent for all the 
patients was obtained from the patient’s guardian.
Genotyping of patients and healthy volunteers
Genotyping was performed as previously described [7].
RNA isolation and cytokine concentration measurements
RNA and cytokine extraction and measurement was per-
formed as described [4].
Immunochemistry
Neutrophils were isolated from 30  ml of venous blood 
obtained from four healthy donors after ethics committee 
approval (ethics committee of the Essen University Hos-
pital, Essen, Germany) and a written informed consent. 
Immunostaining was performed with an AQP5 antibody 
[AQP5 G-19; sc-9890] as described previously [17].
Stable transfection of jurkat T‑cells
Stable transfection with Jurkat T-cells was performed 
using an AQP5_pReceiver EX-T1015-M09 vector 
(Human Full ORF-Clone, NM-001651, pReceiver-M09) 
or a pReceiverM09 (GeneCopeia, Rockville, MD, USA). 
The vector was linearized with ScaI (New England Bio-
labs, Ipswich, MA, USA) and transfected into Jurkat cells 
by electroporation using the Gene Pulser Xcell Elec-
troporation System (BioRad, Munich, Germany). The 
cells were maintained in RPMI plus 10% FKS, plus Pen/
Strep plus 1.1  mg/ml geniticin disulfate. Positive clones 
were selected using limiting dilution [18].
Western blot
For protein extraction, stable transfected Jurkat cells or 
Chemotactic peptide (N-Formyl-l-methionyl-l-leucyl-
l-phenylalanine, fMLP) stimulated HL-60 (10−8M fMLP 
for 6 h) promyelocyte cells were lysed with RIPA buffer 
and proteins were extracted by shaking at 4 °C. Western 
Blot was performed as described [19].
Real‑time PCR
RNA from blood cells of septic patients was extracted as 
described above and 0.5 µg RNA was used to synthesize 
cDNA. In addition RNA from fMLP stimulated HL-60 
cells (10−8M for 6  h) was extracted and 1  µg RNA was 
used for cDNA synthesis. Primers for AQP5 and the 
housekeeping gene actin were used and the real-time 
PCR was performed as described [19, 20].
Neutrophils migration assay
Blood samples (30 ml) from 8 AQP5-genotyped healthy 
volunteers (EDTA-Monovetten Sarstedt, Nümbrecht, 
Germany) were centrifuged at 500g for 30  min using 
30 ml Polymorphprep (Fresenius Kabi, Oslo, Norway). 
Neutrophils were collected. Their purity was deter-
mined using “Scil Vet ABC” cell counter (Scil, Viern-
heim, Germany) and was above 90%. 5 * 105 cells were 
deposited in 200  µl RPMI into the upper compart-
ment of a filter migration assay system containing a 
polycarbonate membrane filter (5  µm pore size, BD, 
Heidelberg, Germany). The lower compartment con-
tained 10−8 M fMLP (Sigma-Aldrich, Taufkirchen, 
Germany) in 500  µl RPMI or control media. The cells 
were incubated at 37 °C with 5% CO2 in air for 0.5 and 
1.5 h in duplicate for each sample as described before 
[21]. The migrated cells were counted after 0.5 and 1.5 
h using the MUSE Count & Viability Kit (Merck Mil-
lipore, Darmstadt, Germany). On the one hand total 
migrated cells (all cells which migrated to RPMI con-
taining 10−8 M fMLP) and on the other hand target ori-
ented migrated cells (difference between cells migrated 
to RPMI containing 10−8 M fMLP and spontaneously 
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migrated cells to RPMI alone) were counted and 
calculated.
For the migration assay with Jurkat T-cells, stable trans-
fected cells were used. Polycarbonate membrane filters 
were coated with 6.3 µg fibronectin and 5 * 105 cells were 
deposited in 200 µl RPMI into the upper compartment. 
The lower compartment contained 100  ng/ml SDF-1α 
(PROSPEC, East Brunswick, NJ, USA) in 500  µl RPMI 
or control media. Cells were counted using the MUSE 
Count & Viability Kit after 4.5 h and again after 24 h.
Statistical analysis
Continuous variables are summarized as boxplots. For 
the comparison of continuous variables of two independ-
ent groups, we used exact Wilcoxon–Mann–Whitney 
tests; for two dependent groups exact Wilcoxon signed-
rank tests. The time-to-event survival variable was sum-
marized as the Kaplan–Meier estimator. The reported 
p-values are two-sided and within each panel adjusted for 
multiplicity by Bonferroni’s correction. A p value of <0.05 
was regarded as statistically significant. All statistical 
analyses were done using GraphPad Prism 6 (La Jolla, 
CA, USA) or IBM SPSS Statistics 21.
Results
Survival of Aqp5‑KO and wild type mice 
after intraperitoneal LPS injection
Seven-day survival following LPS injection differed 
between Aqp5-KO and WT mice. Fifty-six percent 
(10/18) of the Aqp5-KO mice but only 22% (4/18) of the 
WT mice survived for seven days (Fig. 1a). Overall, WT 
mice had a higher risk of death (fully adjusted hazard 
ratio (HR):2.48, 95% CI 1.04–5.90) compared to Aqp5-
KO mice. The administration of LPS caused a quick onset 
of clinical signs of a systemic inflammatory response, 
such as reduced motor activity, lethargy, shivering, and 
weight loss. In general, these clinical signs were more 
severe in wild type than in Aqp5-KO mice. After 96  h, 
WT mice showed a significantly increased disease score 
compared to KO mice (Fig.  1b). To clarify if different 
cytokine expressions might be responsible for differences 
in survival in wild type and KO mice, we examined serum 
concentrations of tumor necrosis factor alpha (TNF-α), 
as one of the early pro-inflammatory cytokines [22], and 
of interleukin-10 (IL-10), as an important anti-inflam-
matory cytokine in sepsis [23]. We did not observe evi-
dence for differences in cytokine concentrations of IL-10 
and TNF-α in the blood of the Aqp5-KO and WT mice 
(Fig. 1c, d).
Migration of neutrophils in mice tissues
First we analyzed total cell count in the peritoneal lav-
age of Aqp5-KO and WT mice. Aqp5-KO mice had 
significant deceased cell count in the lavage compared 
to WT mice (Fig.  2a). Furthermore we analyzed the 
percentage of CD11c Ly6G/C positive cells in the peri-
toneum of Aqp5-Ko and WT mice at 3 h after i. p. LPS 
administration compared to saline injected control mice 
with flow cytometry (Fig. 2b). In WT mice percentage of 
CD11c Ly6G/C positive cells significantly increased after 
3 h LPS compared to saline (Fig. 2c), whereas no signif-
icant increase was detected in Aqp5-KO mice 3  h after 
LPS compared to saline injection. Hence, we found a sig-
nificantly higher amount of CD11c Ly6G/C positive cells 
in the peritoneum, of WT mice compared to Aqp5-KO 
mice (Fig. 2d) after LPS administration.
In the lungs of WT mice a higher number of neu-
trophils were detected compared to Aqp5-KO mice 
after NASDCL-Esterase staining on fixed lung samples 
(Fig. 2e). In line with this MPO activity increased in lungs 
of WT mice after 3  h LPS in comparison with saline 
injection, but not in Aqp5-KO mice (Fig.  2f ). Therefore 
3  h after LPS administration WT mice showed signifi-
cantly higher MPO activity compared to Aqp5-KO mice 
(Fig. 2f ) in lungs.
AQP5‑dependent cell migration of a human cell line
We used the Jurkat cell line for several reasons: (1) Jur-
kat cells can be transfected by routine protocols [28], (2) 
migration assay for Jurkat cells is well established using 
the chemoattractant SDF-1α [29], and (3) we could 
address AQP5  s impact on granulocytes’ (neutrophils) 
and lymphocytes’ (Jurkat) migration. As shown in Fig. 3a 
and validated by Western blot, Jurkat cells could be suc-
cessfully stable transfected with an AQP5 overexpression 
vector and with a control vector. AQP5 transfected Jur-
kat cells showed a 2.4-fold increase in total cell migra-
tion compared to cells transfected with the control vector 
(Fig. 3b).
Genotype‑dependent AQP5 expression and migration 
of human neutrophils
Neutrophils from healthy donors with AA genotype 
showed a considerable amount of AQP5 protein while no 
clear AQP5 protein expression could be detected in CC 
genotype carriers (Fig. 3c). Neutrophils of AA-genotype 
carriers already showed target-oriented migration after 
0.5 h, while neutrophils from AC/CC-genotypes did not 
(Fig. 4a, b). After 1.5 h, neutrophils from AC/CC-geno-
type carriers also showed target-oriented migration, but 
the amount of migrating cells was threefold lower than 
in AA-genotype carriers (Fig. 4c, d). In addition, incuba-
tion of the neutrophil cell line HL-60 with the chemotac-
tic peptide fMLP increased the AQP5 mRNA expression 
(Fig.  5a). In line with that an increase in AQP5 protein 
expression was also evident by Western blot (Fig. 5b).
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AQP5 expression and cytokine concentrations in septic 
patients
To conclude, we examined if AQP5 expression in sep-
tic patients differs between A and C-allele carriers as we 
showed it in neutrophils of healthy donors. The AQP5 
mRNA expression was greater in the blood of septic 
patients carrying the AQP5 AA genotype compared to 
those carrying the AC genotype (Fig.  5c). In addition, 
TNF-α concentration in the blood of septic patients was 
determined depending on AQP5 genotype. Again as in 
mice (Fig.  1d), there was no evidence for AQP5-geno-
type dependent differences in TNF-α concentration 
(Fig. 5d).
Discussion
This study suggests that AQP5 might be an important 
protein in LPS induced systemic inflammation and iden-
tifies the influence of AQP5 expression on immune cell 
migration as a potential mechanism by which the AQP5 
expression affects survival in sepsis. Furthermore, we 
showed that the C-allele, associated with decreased 
AQP5 expression and increased survival from severe sep-
sis, is associated with a decreased neutrophil cell migra-
tion in vitro. Thus, the link between the AQP5-1364A/C 
polymorphism and sepsis survival could be due to AQP5 
expression and its impact on neutrophil cell migration. 
Less cell migration can cause less tissue damage caused 
Fig. 1 Survival, disease score and cytokine serum concentrations of Aqp5-knockout and wild type mice after intraperitoneal lipopolysaccharide 
injection. a Kaplan–Meier plot of overall survival of Aqp5-KO and WT mice after i.p. application of 20 mg/kg bodyweight lipopolysaccharide (LPS) or 
saline (NaCl) (n = 18 per group, saline: n = 8). 56% (10/18) of the Aqp5-KO mice but only 22% (4/18) of the WT mice survived for 7 days (p = 0.04). 
b Disease score recorded at different time points after LPS injection. WT mice showed a significantly increased disease score compared to Aqp5-KO 
mice (p = 0.028) after 96 h. c, d Interleukin-10 and tumor necrosis factor alpha serum concentrations of Aqp5-KO and WT mice measured 4.5 and 
24 h after intraperitoneal LPS injection. IL-10 concentrations (c, n = 7, 9, 10, 9); TNF-alpha concentration (d, n = 13, 12, 12, 11) No differences were 
detected in concentrations of these cytokines between Aqp5-KO and WT mice. p ≫ 0.05 for all comparisons between Aqp5-KO and WT mice. b–d 
Data are shown as boxplots (min to max)
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by infiltrating neutrophils and pro-inflammatory media-
tors [12, 24]. Another possible mechanism which was not 
examined in this study is the potential impact of AQP5 
expression on neutrophil maturation. If AQP5 influences 
maturation the impact on cell migration would only be 
indirectly but it would still have the same impact on 
course of sepsis.
Despite great efforts in research and clinical treatment 
made in the last 30  years, the sepsis mortality remains 
unabatedly high [25]. Accordingly, new approaches are 
urgently needed. Our previous association study suggested 
that AQP5 seems to be a key protein in severe sepsis. Sub-
stitution of C for A at position −1364 was associated with 
decreased AQP5 protein expression and was a strong and 
independent prognostic factor for decreased 30-day mor-
tality in patients with severe sepsis [9]. Therefore this study 
is in line with our previous study, which also showed a 
twofold decreased AQP5 mRNA and protein expression 
in C-allele carriers compared to A-allele carriers [7]. Our 
investigation of Aqp5-KO mice in comparison with WT 
mice now confirms our hypothesis that the AQP5 expres-
sion itself has a particularly strong influence on the mor-
tality of sepsis and that this influence is associated with 
decreased neutrophil migration.
Findings from Vassiliou et  al. support our results [19, 
26] that aquaporins seem to be important target proteins 
Fig. 2 Neutrophil migration in peritoneum and lung 3 h after LPS or saline injection i.p. (20 mg/kg). a Total cell count in the peritoneum was 
1.2 * 106 cells/ml in median in Aqp5-KO mice compared to 2.5 * 106 cells/ml in WT mice (n = 8; p = 0.04). b Representative dot plots show flow 
cytometric analysis of CD11c and Ly6G/C positive cells in the peritoneum. CD11c Ly6G/C positive cells were increased in WT mice compared to 
Aqp5-KO mice after LPS injection c Percentage of CD11c Ly6G/C positive cells in the peritoneum. In WT mice (n = 4) percentage of CD11c Ly6G/C 
positive cells significantly increased after LPS injection compared to saline injection (p = 0.017) and was higher compared to Aqp5-KO mice (n = 4) 
(p = 0.035). d Total cell count of CD11c Ly6G/C positive cells (n = 8; p = 0.04). e Representative NASDCL-Esterase staining of formalin fixed lung 
tissues (40× magnification). WT mice (n = 2) showed higher number of neutrophils compared to Aqp5-KO (n = 2) mice (red arrows) after 3 h LPS 
injection f Myeloperoxidase (MPO) activity in mice lungs. In WT mice (n = 4) MPO activity significantly increased after LPS injection compared to 
saline (p = 0.04) and was higher compared to Aqp5-KO mice [n = 4 (p = 0.004) f]. Data are shown as boxplots (min to max; n = 8 in total)
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in sepsis, as they identified AQP1 as a gene that is up-
regulated in LPS induced inflammation. Importantly, 
an AQP1 upregulation not only took place in lung tis-
sue [19] but also in leukocytes. Vassiliou et  al. showed 
that the AQP1 expression induced by LPS was associ-
ated with increased cell membrane permeability [26]. In 
our study, we examined cell migration and showed that 
increased AQP5 expression is accompanied by increased 
neutrophil migration. The precise mechanism of AQP5 
induced immune cell migration has not been clarified 
yet. Recently the mechanism of AQP9 induced neu-
trophil migration could be elucidated [27] and a simi-
lar mechanism was described for AQP1 [6]. Basing on 
these findings we can speculate on the mechanism of 
AQP5 induced cell migration. AQP5 could be phos-
phorylated by fMLP pathway and then translocated to 
the plasma membrane. Furthermore AQP5 expression 
could be increased by fMLP pathway, possibly via the 
transcription factor nuclear factor of activated T cells 1 
(NFAT1) [28]. Increased AQP5 expression and localiza-
tion of AQP5 to the plasma membrane leads to an influx 
of water and creation of a lower concentration of actin 
monomers which directs a flow of actin monomers to 
the site. Actin monomers polymerize and form a stable 
lamellipodium which leads to cell migration [6].
In this study, we also showed that AQP5 overexpres-
sion in the Jurkat lymphocyte cell line enhances SDF-1α 
induced migration. Interestingly, although SDF-1α is 
found ubiquitously throughout the body, lymphocytes 
from septic patients show increased migration towards 
SDF-1α [30].
We also demonstrate that fMLP induces AQP5-
dependent neutrophil cell migration through a mem-
brane. The process seems to amplify itself as we showed 
that fMLP increases AQP5 expression in the promye-
locyte cell line HL-60. Neutrophil cell migration is an 
important mechanism occurring in sepsis [31, 32]. On 
the one hand, a decrease in neutrophil cell migration to 
the infected organs is associated with a bad outcome of 
sepsis, due to incomplete bacteria eradication [33]. On 
the other hand, neutrophils release large amounts of 
proteases and reactive oxygen species, which not only 
Fig. 3 Western blot and migration assay of transfected Jurkat-cells and AQP5-immunostaining of neutrophils obtained from healthy donors a 
Western blot from whole cell lysates of Jurkat-cells (lane u untransfected cells, lane c transfected with control plasmid, lanes 1–3 AQP5_pReceiver 
transfected Jurkat cells) with AQP5 and ACTB antibody; As indicated by the stronger band in lanes 1–3, Jurkat cells could successfully be stable 
transfected; b Migration assay performed with cell culture inserts utilizing transfected Jurkat cells stimulated with SDF-1α and counted after 22 h 
(n = 6, 6); AQP5 overexpressing (AQP5_pRec) cells showed increased migration (p = 0.009) compared to control cells (pRec). c Representative 
examples of immunostaining with AQP5 antibody of neutrophils obtained from two healthy AA genotype carriers showing a considerable amount 
of AQP5 protein (brown precipitate). In neutrophils of two CC genotype carriers no clear AQP5 protein expression is detected. Every staining was 
performed in duplicate and eight random photographs were taken from each slide, 40× magnification
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kill bacteria but also damage host tissues [34]. Therefore, 
an overwhelming neutrophil cell migration to the tissues 
can cause multiple organ failure, which leads to death 
[34].
Limitations of our study should be mentioned. To our 
surprise, we could not demonstrate in our mouse model 
of LPS induced inflammation that Aqp5-KO is associ-
ated with a decreased cytokine concentration. The lack 
of a genotype dependent effect in cytokine concentra-
tions could be due to the wide variability in cytokine 
production, which is acknowledged both in mice [35] 
and humans [36, 37], and cytokine secretion in itself 
as well as the response to corticoids is influenced by 
genetic variations [3, 4]. In contrast to humans mice 
are inbreed littermates with no genetic variation and 
cytokine differences should have been detected. Other 
studies could detect differences in TNF-α expression 
between KO and wild type mice of other genes [38]. 
Therefore AQP5 might not influence TNF-α pathway 
and other inflammatory proteins might be responsi-
ble for the differences occurring in Aqp5-KO and WT 
animals.
Fig. 4 Migration assay of human primary neutrophils. Migration assays of human primary neutrophils unstimulated or fMLP (target) stimulated 
using cell culture inserts. Migrated cells were counted after 0.5 and 1.5 h (n = 4). Neutrophils from AA-genotype carriers showed target-oriented 
migration already after 0.5 h (a p = 0.029; c p = 0.056). Neutrophils from AC/CC-genotypes did not demonstrate target-oriented migration 
until 1.5 h, and, when compared to AA-genotype carriers, the number of migrated cells was threefold less than the AC/CC-genotype carriers (b 
p = 0.029; d p = 0.029)
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Conclusion
In summary, the AQP5 genotype and AQP5 protein 
expression seem to alter neutrophil cell migration and 
may influence survival in sepsis by altering neutrophil 
cell migration. Therefore AQP5 might be a key protein 
in inflammation and depict a novel target for developing 
sepsis therapeutics.
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